go 6976 has been researched along with Hepatocellular Carcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knoll, S | 1 |
| Fürst, K | 1 |
| Thomas, S | 1 |
| Villanueva Baselga, S | 1 |
| Stoll, A | 1 |
| Schaefer, S | 1 |
| Pützer, BM | 1 |
| Hong, J | 1 |
| Hu, K | 1 |
| Yuan, Y | 1 |
| Sang, Y | 1 |
| Bu, Q | 1 |
| Chen, G | 1 |
| Yang, L | 1 |
| Li, B | 1 |
| Huang, P | 1 |
| Chen, D | 1 |
| Liang, Y | 1 |
| Zhang, R | 1 |
| Pan, J | 1 |
| Zeng, YX | 1 |
| Kang, T | 1 |
| Wu, TT | 1 |
| Hsieh, YH | 1 |
| Hsieh, YS | 1 |
| Liu, JY | 1 |
| Lin, SJ | 1 |
| Chang, C | 1 |
| Ng, AK | 1 |
| Wang, SH | 1 |
| Li, JJ | 1 |
| Hu, CP | 1 |
| Kang-Park, S | 1 |
| Lee, JH | 1 |
| Shin, JH | 1 |
| Lee, YI | 1 |
1 trial available for go 6976 and Hepatocellular Carcinoma
| Article | Year |
|---|---|
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carbazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Prolif | 2012 |
4 other studies available for go 6976 and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carbazol | 2011 |
Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Topics: Carbazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D | 2008 |
Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
Topics: Apoptosis; bcl-Associated Death Protein; Carbazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Hu | 2007 |
Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings.
Topics: Carbazoles; Carcinoma, Hepatocellular; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; He | 2001 |